Oncolytics Biotech, Inc. (ONCY)
0.85
+0.01
(+0.82%)
USD |
NASDAQ |
Aug 24, 16:00
0.85
0.00 (0.00%)
After-Hours: 19:54
Oncolytics Biotech Debt to Equity Ratio : -0.0726 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0726 |
| March 31, 2026 | -0.099 |
| December 31, 2025 | -0.1482 |
| September 30, 2025 | -2.265 |
| June 30, 2025 | 0.1809 |
| March 31, 2025 | 0.154 |
| December 31, 2024 | 0.2307 |
| September 30, 2024 | 0.1175 |
| June 30, 2024 | 0.0609 |
| March 31, 2024 | 0.0491 |
| December 31, 2023 | 0.0153 |
| September 30, 2023 | 0.0177 |
| June 30, 2023 | 0.0215 |
| March 31, 2023 | 0.022 |
| December 31, 2022 | 0.0141 |
| September 30, 2022 | 0.0162 |
| June 30, 2022 | 0.017 |
| March 31, 2022 | 0.0167 |
| December 31, 2021 | 0.0181 |
| September 30, 2021 | 0.0166 |
| June 30, 2021 | 0.016 |
| March 31, 2021 | 0.014 |
| December 31, 2020 | 0.0162 |
| September 30, 2020 | 0.0246 |
| June 30, 2020 | 0.0136 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0187 |
| December 31, 2019 | -4.692 |
| September 30, 2019 | 0.1751 |
| June 30, 2019 | 0.1821 |
| March 31, 2019 | 0.1367 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.0127 |
| Vicapsys Life Sciences, Inc. | -0.1759 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.671M |
| Total Liabilities (Quarterly) | 13.84M |
| Shareholders Equity (Quarterly) | -6.167M |
| Current Ratio | 1.353 |
| Net Debt Paydown Yield | 0.04% |